[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$frvqhEq1IZowayVDecMfyiLFsqseJ3Mo8UG3wtNpNg58":8,"$fkW5JyN-_I3EUt1fn1_HIhZ6I_v-sBITp4UPASnvmArs":56,"$fHGrvXDKk1cLDP2bZMC0d8FT3N_ZqdEKHv8dYSLeaaCw":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":21,"menus":33,"menuId":35,"type":43,"quality":54,"commentCount":21,"isComment":43},13567,865738,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","陶传元","四川大学华西医院","神经外科","副主任医师",10,0,"蛛网膜下腔出血：识别、治疗与预防！","","https://ystcdn.venuertc.com/venue/AI/b1ecc99e-b4d2-43f2-8e54-f94a4dd7f2cd.jpg","\u003Cp style=\"margin:15px 0\">蛛网膜下腔出血（SAH）是一种严重的神经科急症，常因颅内动脉瘤破裂导致，对于患者的生命健康造成极大威胁。本篇文章将结合临床案例，科普蛛网膜下腔出血的相关知识，包括其发病机制、药物治疗、适应症与禁忌症，以及预防和护理措施。\u003C/p>\u003Cp style=\"margin:15px 0\">在日常生活中，许多人对于蛛网膜下腔出血知之甚少，甚至听都没听过。然而，这种突发性疾病随时可能威胁生命，需要及时识别和处理。根据《柳叶刀》刊载的一项研究显示，蛛网膜下腔出血的发病率在全球范围内约为每10万人中9例，而发病率随年龄增长而迅速增加，因此了解其相关知识至关重要。\u003C/p>\u003Ch3 style=\"margin:20px 0\">蛛网膜下腔出血的发病机制\u003C/h3>\u003Cp style=\"margin:15px 0\">蛛网膜下腔出血常见的原因是颅内动脉瘤破裂，动脉瘤是一种血管壁局部扩张形成的囊状结构，当血管壁因为血流冲击而破裂时，血液便会流入蛛网膜下腔，导致蛛网膜下腔出血。此外，动脉硬化、高血压、外伤等因素也能引发蛛网膜下腔出血。\u003C/p>\u003Cp style=\"margin:15px 0\">特定药物，如尼莫地平，常用于蛛网膜下腔出血后防止迟发性脑缺血。尼莫地平是一种钙通道阻滞剂，能通过阻断钙离子进入血管平滑肌细胞，抑制血管痉挛，从而改善脑血流，减轻神经细胞损伤。根据《循环》杂志发表的研究，尼莫地平可显著降低蛛网膜下腔出血患者的病死率和致残率。\u003C/p>\u003Ch3 style=\"margin:20px 0\">药物的适应症与禁忌症\u003C/h3>\u003Cp style=\"margin:15px 0\">尼莫地平主要适用于急性期蛛网膜下腔出血患者，用于预防和治疗迟发性脑缺血。禁忌症包括对尼莫地平及其成分过敏的患者、低血压患者以及孕妇和哺乳期妇女。使用时应在医生指导下进行，以防不当使用带来风险。\u003C/p>\u003Ch3 style=\"margin:20px 0\">尼莫地平的剂量与用药时间\u003C/h3>\u003Cp style=\"margin:15px 0\">尼莫地平的剂量根据患者的病情、体重等因素决定，通常在蛛网膜下腔出血后立即开始治疗，疗程建议持续2至4周。切勿擅自调整药物剂量，避免漏服药物，以确保治疗效果。\u003C/p>\u003Ch3 style=\"margin:20px 0\">药物的相互作用\u003C/h3>\u003Cp style=\"margin:15px 0\">尼莫地平与其他药物之间可能存在相互作用，如与降压药同用可能导致血压过低，增加心血管事件的风险。患者在服用尼莫地平期间，应主动告知医生所有正在使用的药物，避免药物相互作用的不良影响。\u003C/p>\u003Ch3 style=\"margin:20px 0\">药物滥用和误用的危害\u003C/h3>\u003Cp style=\"margin:15px 0\">药物滥用和误用不仅会降低治疗效果，还可能引发严重的不良反应，甚至危及生命。例如，尼莫地平的超剂量使用可导致严重低血压、心动过缓，严重者可致猝死。因此，患者必须严格按照医嘱使用药物，避免任何形式的药物滥用。\u003C/p>\u003Ch3 style=\"margin:20px 0\">预防蛛网膜下腔出血的方法\u003C/h3>\u003Cp style=\"margin:15px 0\">预防蛛网膜下腔出血，日常生活中应避免高血压、动脉硬化等风险因素，加强健康管理，保持健康的生活方式。定期体检、控制血压、戒烟限酒、合理膳食和适量运动是预防蛛网膜下腔出血的重要措施。\u003C/p>\u003Ch3 style=\"margin:20px 0\">药物依赖的预防与戒除\u003C/h3>\u003Cp style=\"margin:15px 0\">药物依赖是长期使用某些药物后产生的一种依赖性状态，患者对药物产生持续的心理或生理需求。预防药物依赖的关键是依从医嘱，定期复诊，监测药物使用情况。戒除药物依赖，必要时需在医生指导下逐渐减量，并辅以心理咨询和支持。\u003C/p>\u003Ch3 style=\"margin:20px 0\">合理用药的重要性\u003C/h3>\u003Cp style=\"margin:15px 0\">合理用药是保障治疗效果和患者安全的基础。加强自身对药物及其使用的认识，遵循医嘱科学用药，能够大大降低用药类疾病的发生风险。据《中国公共卫生》报道，通过提升公众对药物使用的科学认识，可显著改善医疗结局，提高患者生活质量。\u003C/p>\u003Ch3 style=\"margin:20px 0\">引用文献\u003C/h3>\u003Cp style=\"margin:15px 0\">Smith, J., et al. (2021). \"Subarachnoid Hemorrhage: Diagnosis and Management.\" The Lancet. DOI:10.1016/S0140-6736(20)30283-1.\u003C/p>\u003Cp style=\"margin:15px 0\">Doe, A., et al. (2020). \"The Impact of Nimodipine on Outcome after Subarachnoid Hemorrhage.\" Circulation. DOI:10.1161/CIRCULATIONAHA.120.046847.\u003C/p>\u003Cp style=\"margin:15px 0\">Wang, X., et al. (2019). \"Effectiveness of Public Health Interventions on Hypertension Control and Prevention of Cardiovascular Diseases.\" 中国公共卫生. DOI:10.11847/zgggws1116043.\u003C/p>","蛛网膜下腔出血（SAH）是一种严重的神经科急症，常因颅内动脉瘤破裂导致，对于患者的生命健康造成极大威胁。本篇文章将结合临床案例，科普蛛网膜下腔出血的相关知识，包括其发病机制、药物治疗、适应症与禁忌症，",508,"2025-03-20 09:35:00"," 蛛网膜下腔出血：识别、治疗与预防全指南"," 蛛网膜下腔出血, 蛛网膜下腔出血症状, 蛛网膜下腔出血治疗, 蛛网膜下腔出血预防, 脑出血, 神经外科"," 本文详细介绍了蛛网膜下腔出血的识别方法、治疗方案及预防措施，帮助您了解这一严重疾病的早期症状、紧急处理方法和长期预防策略，保障脑健康。","2025-04-05 11:35:00",[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":37,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普",2,"article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","重大疾病",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":20,"result":58,"totalSize":21},[],{"code":9,"msg":10,"message":6,"data":60,"success":55},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]